Abstract
Hepatitis C virus (HCV) is a major etiological agent of chronic liver disease and hepatocellular carcinoma (HCC). We demonstrate herewith that HCV core proteins encoded by sequences isolated from HCC tumor tissues, but not those derived from their non-tumor counterparts in the same liver, co-localise in vitro and in vivo and co-immunoprecipitate with PKR in hepatocytic Huh7 cells. We show that this association in fact augments the autophosphorylation of PKR and the phosphorylation of the translation initiation factor eIF2α, which are two markers of PKR activity. The present study therefore identifies a novel model of virus-cell interactions whereby a viral protein, the HCV core, activates PKR activity.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Abbreviations
- CHX: Cycloheximide:
-
HCV: Hepatitis C Virus, IFNα: Interferon alpha, PKR: double-stranded RNA-dependent protein kinase, TNFα: Tumor Necrosis Factor
References
Barba G, Harper F, Harada T, Kohara M, Goulinet S, Matsuura Y, Eder G, Schaff Z, Chapman MJ, Miyamura T, Brechot C . 1997 Proc. Natl. Acad. Sci. USA 94: 1200–1205
Brechot C . 1998 eds. Boyer, J and Ockner RC Saunders company 183–217
Chen CM, You LR, Hwang LH, Lee YH . 1997 J. Virol. 71: 9417–9426
Clemens MJ, Elia A . 1997 J. Interferon Cytokine Res. 17: 503–524
Gale Jr MJ, Korth MJ, Katze MG . 1998 Clin. Diagn. Virol. 10: 157–162
Gil J, Alcami J, Esteban M . 1999 Mol. Cell Biol. 19: 4653–4663
Heim MH, Moradpour D, Blum HE . 1999 J. Virol. 73: 8469–8475
Honda M, Kaneko S, Shimazaki T, Matsushita E, Kobayashi K, Ping LH, Zhang HC, Lemon SM . 2000 Hepatology 31: 1351–1359
Hsieh TY, Matsumoto M, Chou HC, Schneider R, Hwang SB, Lee AS, Lai MM . 1998 J. Biol. Chem. 273: 17651–17659
Jin DY, Wang HL, Zhou Y, Chun AC, Kibler KV, Hou YD, Kung H, Jeang KT . 2000 EMBO J. 19: 729–740
Kaufman RJ . 1999 Proc. Natl. Acad. Sci. USA 96: 11693–11695
Kim SH, Forman AP, Mathews MB, Gunnery S . 2000 Oncogene 19: 3086–3094
Lai MM, Ware CF . 2000 Curr. Top Microbiol. Immunol. 242: 117–134
Lee JH, Stripf T, Roth WK, Zeuzem S . 1997 J. Med. Virol. 53: 245–251
Lee SB, Bablanian R, Esteban M . 1996 J. Interferon Cytokine Res. 16: 1073–1078
Lu J, O'Hara EB, Trieselmann BA, Romano PR, Dever TE . 1999 J. Biol. Chem. 274: 32198–32203
Major ME, Feinstone SM . 1997 Hepatology 25: 1527–1538
Marusawa H, Hijikata M, Chiba T, Shimotohno K . 1999 J. Virol. 73: 4713–4720
McHutchison JG, Poynard T . 1999 Semin Liver Dis. 19: 57–65
McLauchlan J . 2000 J. Viral. Hepat. 7: 2–14
Naganuma A, Nozaki A, Tanaka T, Sugiyama K, Takagi H, Mori M, Shimotohno K, Kato N . 2000 J. Virol. 74: 8744–8750
Neddermann P, Tomei L, Steinkuhler C, Gallinori P, Tramoitano A, De Francesco R . 1997 Biol. Chem. 378: 469–476
Otsuka M, Kato N, Lan KH, Yoshida H, Kato J, Goto T, Shiratori Y, Omata M . 2000 J. Biol. Chem. 275: 34122–34130
Patel RC, Sen GC . 1998 EMBO J. 17: 4379–4390
Podevin P, Sabile A, Gajardo R, Abadie A, Brechot C, Beretta L . 2001 Hepatology 33: 1503–1511
Polyak SJ, Paschal DM, McArdle S, Gale Jr MJ, Moradpour D, Gretch DR . 1999 Hepatology 29: 1262–1271
Ray RB, Meyer K, Ray R . 1996 Virology 226: 176–182
Ray RB, Meyer K, Steele R, Shrivastava A, Aggarwal BB, Ray R . 1998 J. Biol. Chem. 273: 2256–2259
Ruggieri A, Harada T, Matsuura Y, Miyamura T . 1997 Virology 229: 68–76
Sabile A, Perlemuter G, Bono F, Kohara K, Demaugre F, Kohara M, Matsuura Y, Miyamura T, Brechot C, Barba G . 1999 Hepatology 30: 1064–1076
Santolini E, Migliaccio G, La Monica N . 1994 J. Virol. 68: 3631–3641
Sarrazin C, Zeuzem S . 1999 Z. Gastroenterol. 37: 669–674
Sen GC, Ransohoff RM . 1993 Adv. Virus Res. 42: 57–102
Shimada A, Shiota G, Miyata H, Kamahora T, Kawasaki H, Shiraki K, Hino S, Terada T . 1998 Cancer Res. 58: 4434–4438
Shimotohno K . 1995 Intervirology 38: 162–169
Shimotohno K . 2000 Semin Cancer Biol. 10: 233–240
Song J, Fujii M, Wang F, Itoh M, Hotta H . 1999 J. Gen. Virol. 80: 879–886
Tan SL, Katze MG . 1999 J. Interferon Cytokine Res. 19: 543–554
Tan SL, Nakao H, He Y, Vijaysri S, Neddermann P, Jacobs BL, Mayer BJ, Katze MG . 1999 Proc. Natl. Acad. Sci. USA 96: 5533–5538
Taylor DR, Shi ST, Romano PR, Barber GN, Lai MM . 1999 Science 285: 107–110
Tsuchihara K, Hijikata M, Fukuda K, Kuroki T, Yamamoto N, Shimotohno K . 1999 Virology 258: 100–107
Williams BR . 1999 Oncogene 18: 6112–6120
Yasui K, Wakita T, Tsukiyama-Kohara K, Funahashi SI, Ichikawa M, Kajita T, Moradpour D, Wands JR, Kohara M . 1998 J. Virol. 72: 6048–6055
Yeung MC, Chang DL, Camantigue RE, Lau AS . 1999 Proc. Natl. Acad. Sci. USA 96: 11860–11865
Zhu N, Khoshnan A, Schneider R, Matsumoto M, Dennert G, Ware C, Lai MM . 1998 J. Virol. 72: 3691–3697
Acknowledgements
We thank Y Gourreau, Y Chretien, Dr JP Kolb, Dr MJ Masse and Dr J Wietzerbin for their support.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Delhem, N., Sabile, A., Gajardo, R. et al. Activation of the interferon-inducible protein kinase PKR by Hepatocellular carcinoma derived-Hepatitis C virus core protein. Oncogene 20, 5836–5845 (2001). https://doi.org/10.1038/sj.onc.1204744
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1204744
Keywords
This article is cited by
-
Polymorphisms in the hepatitis C virus core and its association with development of hepatocellular carcinoma
Journal of Biosciences (2017)
-
Look who’s talking—the crosstalk between oxidative stress and autophagy supports exosomal-dependent release of HCV particles
Cell Biology and Toxicology (2017)
-
Hepatitis C virus core triggers apoptosis in liver cells by inducing ER stress and ER calcium depletion
Oncogene (2005)
-
Evasion of intracellular host defence by hepatitis C virus
Nature (2005)
-
Hepatitis C virus core variants isolated from liver tumor but not from adjacent non-tumor tissue interact with Smad3 and inhibit the TGF-β pathway
Oncogene (2005)